WitrynaNeurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy Curr Opin Neurol . 2024 Jun;32(3):500 … WitrynaImportance Chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory hematologic malignant neoplasm causes severe neurologic adverse events ranging from encephalopathy and aphasia to cerebral edema and death. The cause of neurotoxicity is incompletely understood, and its unpredictability is a reason for prolonged …
Cytokine release syndrome and associated neurotoxicity in …
WitrynaThis ESMO Clinical Practice Guideline provides key recommendations for managing immunotherapy-related toxicity. The guideline covers assessment, diagnosis and … Witryna21 lut 2024 · This review will focus on neurotoxicity seen with the most common immunotherapies used in pediatric oncology, including CAR T cell therapy, … getaways in texas on a budget
IJMS Special Issue : CAR-T Cell Therapy 2.0
Witryna17 maj 2024 · Gust, J. et al. Endothelial activation and blood–brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Cancer Discov. 7, 1404–1419 (2024). Witryna19 lut 2024 · Immune effector cell-associated neurotoxicity syndrome (ICANS) is a potentially life-threatening complication of immunotherapy, especially that involving direct activation of T cells. Witryna11 kwi 2024 · Multiple myeloma (MM) is an incurable cancer of the plasma cells. In the last twenty years, treatment strategies have evolved toward targeting MM cells—from the shotgun chemotherapy approach to the slightly more targeted approach of disrupting important MM molecular pathways to the immunotherapy approach that specifically … getaway sleeveless romper